Eli Lilly to buy Ajax Therapeutics for up to $2.3 billion in blood cancer bet - Reuters
Eli Lilly to buy Ajax Therapeutics for up to $2.3 billion in blood cancer bet - Reuters
Eli Lilly to buy Ajax Therapeutics for up to $2.3 billion in blood cancer bet - Reuters
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.